137 related articles for article (PubMed ID: 34464666)
1. LncRNA KCNQ1OT1 depletion inhibits the malignant development of atherosclerosis by miR-145-5p.
Wang Y; Liu L; Li J
Microvasc Res; 2022 Jan; 139():104236. PubMed ID: 34464666
[TBL] [Abstract][Full Text] [Related]
2. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 regulates ox-LDL-induced endothelial cell injury by the miR-218-5p/IGF2 axis in atherosclerosis.
Mao P; Liu X; Wen Y; Tang L; Tang Y
Cell Cycle; 2021 Aug; 20(16):1561-1577. PubMed ID: 34313533
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p/NF-κB Signal Pathway.
Shi Z; Zheng Z; Lin X; Ma H
J Cardiovasc Pharmacol; 2021 Aug; 78(2):235-246. PubMed ID: 34554676
[TBL] [Abstract][Full Text] [Related]
5. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.
Wang G; Chen JJ; Deng WY; Ren K; Yin SH; Yu XH
Cell Death Dis; 2021 Mar; 12(3):254. PubMed ID: 33692340
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-205-5p Promotes Unstable Atherosclerotic Plaque Formation In Vivo.
Meng X; Yin J; Yu X; Guo Y
Cardiovasc Drugs Ther; 2020 Feb; 34(1):25-39. PubMed ID: 32034643
[TBL] [Abstract][Full Text] [Related]
7. lncRNA ZFAS1 promotes ox-LDL induced EndMT through miR-150-5p/Notch3 signaling axis.
Yin Q; He M; Huang L; Zhang X; Zhan J; Hu J
Microvasc Res; 2021 Mar; 134():104118. PubMed ID: 33278458
[TBL] [Abstract][Full Text] [Related]
8. Silencing of GAS5 represses the malignant progression of atherosclerosis through upregulation of miR-135a.
Shen S; Zheng X; Zhu Z; Zhao S; Zhou Q; Song Z; Wang G; Wang Z
Biomed Pharmacother; 2019 Oct; 118():109302. PubMed ID: 31545249
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
10. LncRNA KCNQ1OT1 knockdown inhibits ox-LDL-induced inflammatory response and oxidative stress in THP-1 macrophages through the miR-137/TNFAIP1 axis.
Xu C; Chen L; Wang RJ; Meng J
Cytokine; 2022 Jul; 155():155912. PubMed ID: 35598525
[TBL] [Abstract][Full Text] [Related]
11. MALAT1 overexpression attenuates AS by inhibiting ox-LDL-stimulated dendritic cell maturation via miR-155-5p/NFIA axis.
Chen L; Hu L; Zhu X; Wang Y; Li Q; Ma J; Li H
Cell Cycle; 2020 Oct; 19(19):2472-2485. PubMed ID: 32840181
[TBL] [Abstract][Full Text] [Related]
12. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
[TBL] [Abstract][Full Text] [Related]
13. Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox-LDL-treated human macrophages by upregulating miR-330-5p.
Liu J; Huang GQ; Ke ZP
J Cell Physiol; 2019 Apr; 234(4):5134-5142. PubMed ID: 30187491
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells.
Wang L; Xia JW; Ke ZP; Zhang BH
J Cell Physiol; 2019 Apr; 234(4):5319-5326. PubMed ID: 30259979
[TBL] [Abstract][Full Text] [Related]
15. SPAG5 deficiency activates autophagy to reduce atherosclerotic plaque formation in ApoE
Guo L; Yuan H; Zhu H; Zhou J; Wan Z; Zhou Y
BMC Cardiovasc Disord; 2024 May; 24(1):275. PubMed ID: 38807081
[TBL] [Abstract][Full Text] [Related]
16. LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p/HDAC3/ABCA1 axis.
Yu XH; Deng WY; Chen JJ; Xu XD; Liu XX; Chen L; Shi MW; Liu QX; Tao M; Ren K
Cell Death Dis; 2020 Dec; 11(12):1043. PubMed ID: 33293505
[TBL] [Abstract][Full Text] [Related]
17. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
[TBL] [Abstract][Full Text] [Related]
18. The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis.
Hu WN; Duan ZY; Wang Q; Zhou DH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7628-7638. PubMed ID: 31539155
[TBL] [Abstract][Full Text] [Related]
19. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4.
Lu G; Tian P; Zhu Y; Zuo X; Li X
J Biosci; 2020; 45():. PubMed ID: 32345778
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG16 promoted proliferation and inflammatory response of macrophages through miR-17-5p/NF-κB signaling pathway in patients with atherosclerosis.
An JH; Chen ZY; Ma QL; Wang HJ; Zhang JQ; Shi FW
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8665-8677. PubMed ID: 31646601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
